Ratings Dottikon ES Holding AG

Equities

DESN

CH0582581713

Market Closed - Swiss Exchange Other stock markets 11:30:18 2024-07-12 am EDT			5-day change	1st Jan Change
257 ^CHF	+0.39%		+0.19%	+12.23%

Jun. 21	Correction: Swiss Stocks Tumble Amid Latest PMI Data; Geberit Shares Fall	MT
Jun. 21	Swiss Stocks Tumble Amid Latest PMI Data; Geberit Gains	MT

Summary

According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by -100% by 2027.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.

Weaknesses

With an expected P/E ratio at 34.5 and 34.96 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
DOTTIKON ES HOLDING AG	+12.23%	3.97B	-	D
ELI LILLY AND COMPANY	+62.66%	854B		C+
NOVO NORDISK A/S	+40.42%	636B		B
JOHNSON & JOHNSON	-4.37%	361B		C+
MERCK & CO., INC.	+17.16%	324B		B-
ABBVIE INC.	+9.87%	301B		C+
ASTRAZENECA PLC	+15.66%	247B		B+
ROCHE HOLDING AG	+4.21%	230B		A+
NOVARTIS AG	+17.90%	228B		B-
AMGEN INC.	+14.86%	177B		C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes